Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C56H71N9O23S |
Molecular Weight | 1270.274 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 15 / 15 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@H](O)CN1C(=O)[C@@]([H])(NC(=O)[C@H](C[C@@H](O)[C@@H](O)NC(=O)[C@]3([H])[C@@H](O)[C@@H](C)CN3C(=O)[C@@]([H])(NC(=O)[C@@]([H])(NC2=O)[C@H](O)[C@@H](O)C4=CC(OS(O)(=O)=O)=C(O)C=C4)[C@H](O)CC(N)=O)NC(=O)C5=CC=C(C=C5)C6=NOC(=C6)C7=CC=C(OCCCCC)C=C7)[C@@H](C)O
InChI
InChIKey=PIEUQSKUWLMALL-YABMTYFHSA-N
InChI=1S/C56H71N9O23S/c1-4-5-6-17-86-32-14-11-28(12-15-32)39-21-33(63-87-39)27-7-9-29(10-8-27)49(75)58-34-20-38(70)52(78)62-54(80)45-46(72)25(2)23-65(45)56(82)43(37(69)22-41(57)71)60-53(79)44(48(74)47(73)30-13-16-36(68)40(18-30)88-89(83,84)85)61-51(77)35-19-31(67)24-64(35)55(81)42(26(3)66)59-50(34)76/h7-16,18,21,25-26,31,34-35,37-38,42-48,52,66-70,72-74,78H,4-6,17,19-20,22-24H2,1-3H3,(H2,57,71)(H,58,75)(H,59,76)(H,60,79)(H,61,77)(H,62,80)(H,83,84,85)/t25-,26+,31+,34-,35-,37+,38+,42-,43-,44-,45-,46-,47-,48-,52+/m0/s1
Molecular Formula | C56H71N9O23S |
Molecular Weight | 1270.274 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 15 / 15 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:23:28 UTC 2023
by
admin
on
Sat Dec 16 16:23:28 UTC 2023
|
Record UNII |
R10H71BSWG
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LIVERTOX |
634
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
||
|
WHO-ATC |
J02AX05
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
||
|
NDF-RT |
N0000175508
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
||
|
WHO-VATC |
QJ02AX05
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
||
|
NCI_THESAURUS |
C514
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
||
|
NDF-RT |
N0000175508
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
||
|
NDF-RT |
N0000175507
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
R10H71BSWG
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
PRIMARY | |||
|
C121905
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
PRIMARY | |||
|
100000091615
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
PRIMARY | |||
|
CHEMBL457547
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
PRIMARY | |||
|
235114-32-6
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
PRIMARY | |||
|
1798
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
PRIMARY | |||
|
600520
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
PRIMARY | |||
|
m7524
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
PRIMARY | Merck Index | ||
|
8069
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
PRIMARY | |||
|
325887
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
PRIMARY | RxNorm | ||
|
DB01141
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
PRIMARY | |||
|
DTXSID90873341
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
PRIMARY | |||
|
C1850
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
PRIMARY | |||
|
R10H71BSWG
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
PRIMARY | |||
|
477468
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
PRIMARY | |||
|
MICAFUNGIN
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
PRIMARY | |||
|
SUB16444MIG
Created by
admin on Sat Dec 16 16:23:28 UTC 2023 , Edited by admin on Sat Dec 16 16:23:28 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
BINDER->LIGAND |
When detennined in human plasma samples following a single dose of micafungin I00 mg, micafungin binding to plasma protein were approximately 99.8%. Micafungin protein binding in
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
MINOR
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
Activity Questionable (inactive in http://onlinelibrary.wiley.com/doi/10.1592/phco.27.1.53/epdf). However, not important in theraphy as concentration is low. Mediator: arylsulfatase
PLASMA
|
||
|
METABOLITE -> PARENT |
Probably inactive. Mediator: P450 (CYP) isozymes, but not a major pathway for micafungin metabolism in vivo
PLASMA
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
Population PHARMACOKINETIC PHARMACOKINETIC |
|
||